-
How Hemangiosarcoma Broke Our Hearts
May 27, 2020We hope that Dakota’s story helps those who are unfamiliar with the rapid progression of Hemangiosarcoma to better understand it.
Read Article -
About Intestinal Dysbiosis and why it is a Priority for Ethos Discovery
April 29, 2020Intestinal dysbiosis is an alteration in the composition and/or richness of the normal bacteria that are found in the gastrointestinal tract (microbiota). The effect of intestinal dysbiosis on the progression of various diseases is currently lacking in both human and veterinary medicine. Ethos Discovery now asks what the influence of intestinal dysbiosis is on a variety of non-GI diseases in veterinary patients.
Read Article -
How Clinical Trials Have Intersected with my Practice of Clinical Medicine
March 25, 2020Our President Dr. Chand Khanna shares his thoughts on his career as a practicing veterinary oncologiest, and his approach to innovation and clinical trials. The option of therapeutics only available through clinical trials has been a key feature of his practice of clinical medicine which has delivered many favorable intended and unintended consequences.
Read Article -
A Necessary Shift in Perspective: A First Step Towards Curative Outcomes in Veterinary Oncology
March 18, 2020Ethos Discovery seeks to deliver curative outcomes for pet animals with cancer. Given that the term "cure" has been historically avoided, we do not document or recognize curative outcomes when they occur. As a first step towards raising cancer survivorship, a change in perspective and our assessment of existing data is needed.
Read Article -
Precision Medicine and Canine Hemangiosarcoma
April 30, 2019There are limited therapeutic options for the treatment of hemangiosarcoma, with none currently providing a significant opportunity for long-term survival. Ethos Discovery’s previous work in hemangiosarcoma has taught us that hemangiosarcoma is not a single cancer, but rather at least four different subtypes of cancer.
Read Article
